Comparative Phase II Clinical Trial of R112 for Allergy Treatment

RigelPharmaceuticals, Inc today announced that it has enrolled thefirst patient in a comparative Phase II clinical study of R112, a potentialintranasal therapy for the treatment of allergic rhinitis... click link for more info.

Continue to Comparative Phase II Clinical Trial of R112 for Allergy Treatment on Medical News Today.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz